Maque, Jena .

HRN: 28-85-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
CO-AMOXICLAV 625MG (TAB)
04/16/2026
04/22/2026
PO
625
BID
PROM
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines